Schedule 13D ownership disclosure
Jade Biosciences Inc
Common Stock · CUSIP: 008064206
Event date: 2025-04-28
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Atlas Venture Fund XII, L.P.Reported CIK 0001812049
Shares: 50,992.00 · Class: 0.2%
- Atlas Venture Associates XII, L.P.Reported CIK 0001845875
Shares: 51,406.00 · Class: 0.2%
- Atlas Venture Associates XII, LLCReported CIK 0001845871
Shares: 51,406.00 · Class: 0.2%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001415889-25-011576
- Form type
- SCHEDULE 13D/A
- Filer
- Jade Biosciences, Inc.
- CIK
- CIK 1798749
- Filed
- Apr 30, 2025
- Reporting period
- Apr 28, 2025
- Description
- Schedule 13D beneficial ownership